Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:244-248
Published online before print May 23, 2005, doi: 10.1161/01.HYP.0000166723.07809.7e
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/1/244    most recent
01.HYP.0000166723.07809.7ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verbeke, F.
Right arrow Articles by Van Bortel, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbeke, F.
Right arrow Articles by Van Bortel, L. M.
Related Collections
Right arrow Hypertension - basic studies
Right arrow Other diagnostic testing

(Hypertension. 2005;46:244.)
© 2005 American Heart Association, Inc.


Fifth International Workshop on Structure and Function of Large Arteries

Noninvasive Assessment of Local Pulse Pressure

Importance of Brachial-to-Radial Pressure Amplification

Francis Verbeke; Patrick Segers; Steven Heireman; Raymond Vanholder; Pascal Verdonck; Luc M. Van Bortel

From the Department of Internal Medicine, Nephrology Section (F.V., R.V.), Ghent University Hospital; and the Hydraulics Laboratory (P.S., P.V.), Department of Civil Engineering, and the Heymans Institute of Pharmacology (S.H., L.M.V.B.), Ghent University, Ghent, Belgium.

Correspondence to Francis Verbeke, University Hospital Ghent, Department of Internal Medicine, Nephrology Section, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail francis.verbeke{at}UGent.be


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The advocated SphygmoCor procedure uses a radial-to-aorta transfer function with calibration on brachial instead of radial artery pressure to assess the central pulse pressure. We compared these values with carotid artery pulse pressures obtained from a validated calibration method, assuming mean minus diastolic blood pressure constant throughout the large artery tree. From 44 healthy subjects (21 males; 22 to 68 years) pressure waves were obtained at the radial, brachial, and carotid artery with applanation tonometry. Using the calibration method, radial and carotid artery pressures were assessed from brachial artery waves and pressures. The effect of brachial-to-radial pulse pressure amplification, brachial pulse pressure, mean pressure, age, gender, height, body mass index, and smoking on differences between the 2 methods was assessed. Brachial artery pressure was 118±12/72±10 mm Hg. SphygmoCor central pulse pressure was 9.7±4.6 mm Hg lower (P<0.001) than the carotid artery pulse pressure (33.0±6.8 versus 42.7±8.9 mm Hg). The difference between the 2 methods strongly depended (P<0.001) on brachial-to-radial artery pulse pressure amplification (5.8±5.1 mm Hg; 12±11%) and less on brachial artery pulse pressure (P=0.005). After calibration of the radial pressure wave with radial instead of brachial artery pressures, the difference between SphygmoCor central pulse pressure and carotid pulse pressure decreased with 4 mm Hg. The advocated SphygmoCor procedure systematically underestimates the central pulse pressure with brachial-to-radial pulse pressure amplification as important determinant. Therefore, calibration of radial artery pressure waves on brachial artery pressures should be avoided. The underestimation of central aortic pulse pressure caused by the radial-to-aorta transfer function itself is much less than previously reported.


Key Words: pulse • blood pressure • blood pressure determination • arterial pressure


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Brachial artery (BA) pulse pressure (PP) is a strong and independent predictor of cardiovascular morbidity and mortality in the general population,1 patients with hypertension,2 coronary heart disease,3 and end-stage renal disease.4 Although this peripheral PP is of great clinical value, from a pathophysiological point of view it seems more logical to presume that the left ventricle is merely affected by the central aortic pressure opposing the left ventricular ejection.5,6 Because PP is not constant throughout the large artery tree, BA PP may not be a good surrogate for central aortic PP.7,8

Methods have been developed to measure central blood pressure. One method has been proposed by Kelly and Fitchett.9 It makes use of calibration on pressure waveforms obtained at superficial arteries with applanation tonometry. This method assumes that mean arterial pressure (MAP) minus diastolic blood pressure is constant throughout the large artery tree9 and has been found accurate.10 Alternatively, radial-to-aorta pressure transfer can be used to mathematically transform radial artery (RA) waveforms into central aorta waveforms. A population-based radial-to-aorta transfer function is used in the SphygmoCor device (AtCor Medical Pty Ltd, Sydney, Australia). The advantage of this technique is the ease to perform applanation tonometry at the RA. Although this transfer function has been validated,11 the accuracy of central aortic PP obtained with the SphygmoCor has been largely debated.12–19 The debate focused mainly on the validity of the transfer function but ignored a second possible source of error in the advocated SphygmoCor procedure: calibration of the RA wave with brachial instead of radial blood pressure values.

We hypothesize that both the generalized transfer function and the use of BA blood pressure values as surrogate of RA blood pressure contribute to the presumed erroneous assessment of central PP by SphygmoCor. The present study investigates this hypothesis as well as the relative contribution of the 2 procedures. The validated calibration method proposed by Kelly and Fitchett is used as reference method.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects and Study Design
Healthy subjects aged 18 to 70 years were eligible. Smoking was not allowed for 3 hours before the study. Measurements were performed while subjects were in a quiet environment after at least 10 minutes of supine rest. Local blood pressures were in random order consecutively assessed with the calibration method (CAL) and the SphygmoCor (Figure 1). Assessment of local pressures was preceded and followed by conventional measurement of the ipsilateral BA blood pressure with a sphygmomanometer. The mean of arm blood pressure values was used to calibrate the 2 methods. The calibration method was used to calculate the PP at the radial (PPRA–CAL) and carotid artery (CA) (PPCA–CAL). The SphygmoCor was used to calculate the aortic PP from RA waveforms applying a radial-to-aorta transfer function (PPAO–RTF) and from CA waveforms applying a carotid-to-aorta transfer function (PPAO–CTF). All reported data are mean values of 3 consecutive high-quality recordings. The study was approved by the local ethics committee and written informed consent was obtained from all subjects.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Study design. Randomized crossover design for procedures, preceded and followed by brachial blood pressure measurements using a validated oscillometric device (Omron BP). Calibration indicates calibration method according to Kelly and Fitchett; BA, brachial artery; RA, radial artery; CA, carotid artery; RTF, radial-to-aorta transfer function; CTF, carotid-to-aorta transfer function.

Measurements and Derived Parameters
BA blood pressure was measured with a validated20 oscillometric device (Omron HEM-705CP; Omron Healthcare Europe), and the mean of the 3 stable (coefficient of variation <5%) consecutive measurements was subsequently used. MAP was estimated from the numeric integral of the BA pressure wave over time measured with applanation tonometry, calibrated with the systolic and diastolic BA blood pressure. PP (PPBA) was defined as the difference between systolic and diastolic blood pressure.

Arterial pressure waves were recorded at the BA, RA, and common CA using applanation tonometry. For both the calibration method and the SphygmoCor, the same applanation tonometer was used (Millar SPT-301B probe; Millar Instruments, Houston, Tex). For the calibration method, a dedicated homemade data acquisition system was used consisting of a hardware set-up (NI SC 2345; National Instruments, Houston, Tex) connected to a personal computer and post-processing software written in Matlab 6.0 (The Mathworks). This device allowed to calculate an average waveform over a defined time period (Figure 2).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Calibration method according to Kelly and Fitchett. Scaling of carotid pressure wave from brachial artery (systolic and diastolic) pressure and wave, assuming that the mean and diastolic pressures are constant throughout the large artery tree. SBP indicates systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure. The subscript BA indicates values at the brachial artery and CA at the carotid artery. The tonometer signal is in arbitrary units (AU).

Aortic PP was assessed in several ways: (1) PPAO–RTF was calculated according to the advocated SphygmoCor procedure, using a population based generalized radial-to-aorta transfer function with RA waveform calibration on BA blood pressure; (2) PPAO–RTFimp also used the radial-to-aorta transfer function, but RA waveform calibration was performed on RA pressures; and (3) PPAO–CTF was obtained from CA waveforms, calibrated on the carotid pressures obtained with the calibration method, and using the carotid-to-aorta transfer function in the SphygmoCor. PPCA–CAL was used as primary estimate of aortic pressure (reference method) and PPAO–CTF as secondary estimate.

PP amplification between different arterial sites was expressed as the absolute difference between PPs at each site and in percent amplification. For example, PP amplification from brachial-to-RA (PPamplBA–RA) was calculated as follows: absolute PPamplBA–RA=PPRA–CAL–PPBA and in percent PPamplBA–RA=(PPRA–CAL/PPBA–1)* 100.

Statistics
Demographic data are presented as numbers or means±SD. Bland–Altman plots were used to evaluate the agreement between estimates of the same parameter; the mean difference between estimates reflects systematic bias and the SD of the differences [between estimates reflects], the level of agreement.21 Reproducibility was assessed by calculating the coefficients of variation. Differences in PP were examined by paired-samples t tests or Wilcoxon signed ranks tests for normal or not normal distributed variables, respectively. The effect of age, gender, height, body mass index, smoking status, PPamplBA–RA, MAP, and BA PP on the differences in aortic PP between radial-to-aorta transfer function and reference method was assessed using multiple linear regression analysis. P<0.05 was considered significant. Statistical analysis was performed using SPSS 11.0.1 for Windows (SPSS Inc).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Forty-four subjects entered the study. Subject characteristics are shown in Table 1. Peripheral and central PP according to different methods are given in Table 2. Reproducibility of the MAP, radial, and carotid systolic pressure obtained with the calibration method was high with a coefficient of variation of 0.9%, 1.6%, and 0.9%, respectively. The carotid-to-BA PP amplification was 3.1±5.4 mm Hg (7±13%) and was smaller than the brachial-to-radial PP amplification of 5.8±5.1 mm Hg (12±11%) (P=0.002). Brachial-to-radial PP amplification was only dependent on gender (women less than men; P=0.006), not on age, height, body mass index, smoking, BA PP, and MAP.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Subject Characteristics


View this table:
[in this window]
[in a new window]
 
TABLE 2. Peripheral and Central Pulse Pressures

PPAO–RTF was always lower than the aortic PP obtained with any of the 2 candidate reference methods (PPCA–CAL, PPAO–CTF). The difference with PPCA–CAL is shown in Figure 3a. The use of brachial instead of RA pressures to calibrate the radial pressure wave resulted in an underestimation of mean arterial pressure by 3.2±1.8 mm Hg. Calibration of the RA wave with RA pressures instead of BA pressures resulted in an increase of estimated central PP from 33.0±6.8 mm Hg (PPAO–RTF) to 37.1±8.2 mm Hg (PPAO–RTFimp). At the same time, the difference with the candidate reference methods decreased with 4 mm Hg (–9.7 to –5.7 mm Hg when compared with PPCA–CAL; –7.1 to –3.1 mm Hg when compared with PPAO–CTF) but remained statistically significant (Table 2). The difference with PPCA–CAL is shown in Figure 3b.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 3. Bland–Altman graphs of differences in pulse pressure at the carotid artery (obtained with the calibration method, PPCA–CAL) and (a, left panel) at the aorta obtained with the advocated SphygmoCor procedure (calibrated on brachial artery pressures, PPAO–RTF) and (b, right panel) at the aorta obtained with the improved SphygmoCor procedure (calibrated on radial artery pressures, PPAO–RTFimp).

In multiple linear regression analysis, the difference between PPAO–RTF and PPCA–CAL appeared to be strongly dependent on PPamplBA–RA and brachial PP, but not on MAP, age, gender, smoking status, height, or body mass index (Table 3). PPamplBA–RA and brachial PP together explained 69% of the variation (63% for PPamplBA–RA) between the 2 methods (adjusted R2=0.69, P<0.001).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Determinants of Difference Between PPCA–CAL and PPAO–RTF


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Estimation of central aortic hemodynamic parameters such as PP and augmentation index from the radial pulse using a transfer function has become common practice.22–29 Several validation studies confirmed the accuracy of the transfer function for estimation of both aortic PP and aortic augmentation index.11 In a majority of these studies, the pressure curve was calibrated using invasive blood pressure measurements.11,30–33 When noninvasive calibration was performed, conforming to the noninvasive nature of the technique, a considerable bias in the estimation of the central PP was observed.14,15 However, as in these studies, aortic pressures obtained from invasive measurements were compared with the SphygmoCor procedure calibrated on noninvasively obtained arm blood pressure, it was not clear whether the observed difference between methods was caused by the SphygmoCor procedure, the deviation of sphygmomanometer blood pressures from invasive pressures, or both. To eliminate this potential source of bias, in the present study, both SphygmoCor and calibration method were calibrated on the same blood pressure values obtained noninvasively with a validated device (Omron HEM 705 CP).

In the present study, we identified inadequate calibration caused by centrifugal PP amplification and transfer function effects as major source of bias in the estimation of the central PP using the SphygmoCor when compared with PPCA–CAL, a validated calibration method.10 Because the primary objective was to verify the accuracy of the SphygmoCor procedure as advocated by the manufacturer, we initially compared the PPAO–RTF with the PPCA–CAL, which yielded a systematic underestimation of 9.7±4.6 mm Hg by PPAO–RTF. This systematic bias is lower than the 19.0 to 24.8 mm Hg observed in studies14,34 comparing the PPAO–RTF with invasively measured central PP, and supports the view of O’Rourke et al that a large part of the difference found in these studies was caused by the difference between sphygmomanometer and invasive blood pressure values.17

The present study identified a substantial PP amplification between brachial and RA (average 12%), larger than the carotid-to-brachial PP amplification. Because the SphygmoCor procedure advocates the use of brachial instead of RA pressure to calibrate the radial pressure wave, a substantial error is introduced accounting for {approx}4 mm Hg of underestimation. Because PP amplification may vary considerably, the degree of underestimation by using brachial pressure values as a surrogate for RA pressure is unpredictable. The brachial-to-radial PP amplification largely determined the underestimation of aortic PP (estimated by PPCA–CAL) by the advocated SpygmoCor procedure (PPAO–RTF). The level of PP was the only additional but less important determinant of this underestimation.

After calibration of the RA pressure wave with RA pressure obtained with the calibration method (PPRA–CAL) the difference between PPAO–RTFimp and PPCA–CAL decreased to 5.7 mm Hg. The question remains whether this residual difference can be attributed to the transfer function itself. We used the PP at the CA obtained with the calibration method PPCA–CAL as surrogate for PP in the ascending aorta. The important question is whether PPCA–CAL is a valid surrogate for aortic PP. Although some authors have shown that the PP in the common CA and in the ascending aorta is identical,30 other studies indicate a small difference.10 In a validation study of the calibration method, CA PP was found on average 1.8±5.2 mm Hg higher than ascending aortic PP.10 Another way of obtaining surrogate aortic PP is to calculate aortic pressure from carotid waveforms via a carotid-to-aorta transfer function (PPAO–CTF), presuming that the carotid-to-aorta transfer function is valid. This method shows aortic PP to be 2.6 mm Hg lower than at the CA and reduces the residual underestimation of the aortic pressure to 3.1 mm Hg. Thus, depending on the candidate estimate of aortic PP, the residual underestimation is between 3.1 and 5.7 mm Hg. This residual underestimation of aortic pressure may be caused by the generalized population-based transfer function itself, but is larger than the 0.7±4.2 mm Hg found by Pauca et al in an invasive study11 in anesthetized patients.

The present study shows that depending on the candidate estimate of aortic PP used, the average error from the CA PP as surrogate for aortic PP (ranging between 0 and +2.6 mm Hg) is smaller than the average error (ranging between –3.1 and –5.7 mm Hg) from the improved SphygmoCor procedure using RA pressures. This supports the idea that CA pressure can be used as surrogate for central aortic pressure. A drawback of the calibration method and the improved SphygmoCor method is the need for an additional tonometry at the BA as long as reliable RA pressures from noninvasive devices are not available.

This study had some limitations. First, we did not have invasive blood pressure measurements in the present study. However, simultaneous comparison of invasive pressures at different arterial sites, like in the present study, might pose ethical problems, especially in a healthy population. In addition, the reference method had previously been validated against invasive measurements.10 Second, the calibration and SphygmoCor methods were performed consecutively and during this time blood pressure could have changed. To limit this bias, CAL and SphygmoCor procedures were performed in random order and both procedures were calibrated on the same BA blood pressure values. This procedure is presumed to limit systematic bias but cannot avoid variation between methods.

Perspectives
The use of BA pressure as surrogate for RA pressure in the advocated SphygmoCor procedure is an important source of error and should be avoided. This means a real need for an easy and reliable method to measure RA blood pressure noninvasively. Although oscillometric wrist sphygmomanometers have been developed, they do not provide RA pressures, because they have been calibrated on BA pressures. As long as direct accurate noninvasive measurement of RA pressure is not available, the more complex calibration method by Kelly and Fitchett remains advocated. The underestimation of central aortic PP caused by the radial-to-aorta population-based transfer function itself is much less than previously reported by some authors. However, its validity in different situations has not been fully established. Future research should further validate this and other transfer functions. Progress could be made by automation of the calibration method proposed by Kelly and Fitchett and by developing alternative methods for handheld applanation tonometers to obtain arterial pressure waves at different arterial sites.

Received February 11, 2005; first decision February 28, 2005; accepted April 6, 2005.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997; 30: 1410–1415.[Abstract/Free Full Text]

2. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens. 1999; 17: 1065–1072.[CrossRef][Medline] [Order article via Infotrieve]

3. Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation. 1997; 96: 4254–4260.[Abstract/Free Full Text]

4. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001; 38: 434–438.[Abstract/Free Full Text]

5. Westerhof N, O’Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995; 13: 943–952.[Medline] [Order article via Infotrieve]

6. Vlachopoulos C, O’Rourke M. Genesis of the normal and abnormal arterial pulse. Curr Probl Cardiol. 2000; 25: 303–367.[CrossRef][Medline] [Order article via Infotrieve]

7. Kelly RP, Gibbs HH, O’Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J. 1990; 11: 138–144.[Abstract/Free Full Text]

8. Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest. 1992; 102: 1193–1198.[CrossRef][Medline] [Order article via Infotrieve]

9. Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J Am Coll Cardiol. 1992; 20: 952–963.[Abstract]

10. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, Vredeveld JW, Safar ME, Struijker Boudier HA, Hoeks AP. Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens. 2001; 19: 1037–1044.[CrossRef][Medline] [Order article via Infotrieve]

11. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001; 38: 932–937.[Abstract/Free Full Text]

12. Millasseau SC, Patel SJ, Redwood SR, Ritter JM, Chowienczyk PJ. Pressure wave reflection assessed from the peripheral pulse: is a transfer function necessary? Hypertension. 2003; 41: 1016–1020.[Abstract/Free Full Text]

13. Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME. Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension. 2003; 42: 150–155.[Abstract/Free Full Text]

14. Cloud GC, Rajkumar C, Kooner J, Cooke J, Bulpitt CJ. Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures. Clin Sci (Lond). 2003; 105: 219–225.[Medline] [Order article via Infotrieve]

15. Davies JI, Band MM, Pringle S, Ogston S, Struthers AD. Peripheral blood pressure measurement is as good as applanation tonometry at predicting ascending aortic blood pressure. J Hypertens. 2003; 21: 571–576.[CrossRef][Medline] [Order article via Infotrieve]

16. Giannattasio C. How to assess central arterial blood pressure? J Hypertens. 2003; 21: 495–496.[CrossRef][Medline] [Order article via Infotrieve]

17. O’Rourke M, Avolio A. Assessment of central arterial pressure? J Hypertens. 2003; 21: 1425–1426.[Medline] [Order article via Infotrieve]

18. Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transfer functions for the derivation of aortic waveform characteristics. J Hypertens. 2003; 21: 1299–1305.[CrossRef][Medline] [Order article via Infotrieve]

19. Hoeks AP, Meinders JM, Dammers R. Applicability and benefit of arterial transfer functions. J Hypertens. 2003; 21: 1241–1243.[CrossRef][Medline] [Order article via Infotrieve]

20. O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001; 322: 531–536.[Free Full Text]

21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307–310.[CrossRef][Medline] [Order article via Infotrieve]

22. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, Frenneaux MP, Cockcroft JR. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002; 39: 1005–1011.[Abstract/Free Full Text]

23. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002; 22: 147–152.[Abstract/Free Full Text]

24. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care. 1999; 22: 1722–1727.[Abstract/Free Full Text]

25. Brooks BA, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in Type 2 diabetes. Diabet Med. 2001; 18: 374–380.[CrossRef][Medline] [Order article via Infotrieve]

26. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003; 41: 183–187.[Abstract/Free Full Text]

27. Deary AJ, Schumann AL, Murfet H, Haydock S, Foo RS, Brown MJ. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci (Lond). 2002; 103: 493–499.[Medline] [Order article via Infotrieve]

28. Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond). 2002; 103: 59–65.[Medline] [Order article via Infotrieve]

29. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001; 37: 1429–1433.[Abstract/Free Full Text]

30. Chen CH, Ting CT, Nussbacher A, Nevo E, Kass DA, Pak P, Wang SP, Chang MS, Yin FC. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996; 27: 168–175.[Abstract/Free Full Text]

31. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997; 95: 1827–1836.[Abstract/Free Full Text]

32. Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993; 14: 160–167.[Abstract/Free Full Text]

33. Fetics B, Nevo E, Chen CH, Kass DA. Parametric model derivation of transfer function for noninvasive estimation of aortic pressure by radial tonometry. IEEE Trans Biomed Eng. 1999; 46: 698–706.[CrossRef][Medline] [Order article via Infotrieve]

34. Takazawa K, O’Rourke M, Fukita M. Estimation of ascending aortic pressure from radial arterial pressure using a generalised transfer function. Z Kardiol. 1996; 137–139.




This article has been cited by other articles:


Home page
HypertensionHome page
P. Segers, D. Mahieu, J. Kips, E. Rietzschel, M. De Buyzere, D. De Bacquer, S. Bekaert, G. De Backer, T. Gillebert, P. Verdonck, et al.
Amplification of the Pressure Pulse in the Upper Limb in Healthy, Middle-Aged Men and Women
Hypertension, August 1, 2009; 54(2): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. P. Avolio, L. M. Van Bortel, P. Boutouyrie, J. R. Cockcroft, C. M. McEniery, A. D. Protogerou, M. J. Roman, M. E. Safar, P. Segers, and H. Smulyan
Role of Pulse Pressure Amplification in Arterial Hypertension: Experts' Opinion and Review of the Data
Hypertension, August 1, 2009; 54(2): 375 - 383.
[Full Text] [PDF]


Home page
HypertensionHome page
J. G. Kips, E. R. Rietzschel, M. L. De Buyzere, B. E. Westerhof, T. C. Gillebert, L. M. Van Bortel, and P. Segers
Evaluation of Noninvasive Methods to Assess Wave Reflection and Pulse Transit Time From the Pressure Waveform Alone
Hypertension, February 1, 2009; 53(2): 142 - 149.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Pletinck, F. Verbeke, L. Van Bortel, C. Dequidt, D. Vijt, W. Van Biesen, and R. Vanholder
Acute central haemodynamic effects induced by intraperitoneal glucose instillation
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4029 - 4035.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. E. Westerhof, I. Guelen, W. J. Stok, H. A. J. Lasance, C. A. P. L. Ascoop, K. H. Wesseling, N. Westerhof, W. J. W. Bos, N. Stergiopulos, and J. A. E. Spaan
Individualization of transfer function in estimation of central aortic pressure from the peripheral pulse is not required in patients at rest
J Appl Physiol, December 1, 2008; 105(6): 1858 - 1863.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Kozakova, C. Palombo, M. Paterni, C.-H. Anderwald, T. Konrad, M.-P. Colgan, A. Flyvbjerg, J. Dekker, and on behalf of the Relationship between Insulin Sens
Body Composition and Common Carotid Artery Remodeling in a Healthy Population
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3325 - 3332.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. A van der Klaauw, A. M Pereira, T. J Rabelink, E. P M Corssmit, A.-J. Zonneveld, H. Pijl, H. C de Boer, J. W A Smit, J. A Romijn, and E. J P de Koning
Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency
Eur. J. Endocrinol., August 1, 2008; 159(2): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Munir, B. Jiang, A. Guilcher, S. Brett, S. Redwood, M. Marber, and P. Chowienczyk
Exercise reduces arterial pressure augmentation through vasodilation of muscular arteries in humans
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1645 - H1650.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Jankowski, K. Kawecka-Jaszcz, D. Czarnecka, M. Brzozowska-Kiszka, K. Styczkiewicz, M. Loster, M. Kloch-Badelek, J. Wilinski, A. M. Curylo, D. Dudek, et al.
Pulsatile but Not Steady Component of Blood Pressure Predicts Cardiovascular Events in Coronary Patients
Hypertension, April 1, 2008; 51(4): 848 - 855.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Verbeke, W. Van Biesen, P. Peeters, L. M. Van Bortel, and R. C. Vanholder
Arterial stiffness and wave reflections in renal transplant recipients
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3021 - 3027.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Agabiti-Rosei, G. Mancia, M. F. O'Rourke, M. J. Roman, M. E. Safar, H. Smulyan, J.-G. Wang, I. B. Wilkinson, B. Williams, and C. Vlachopoulos
Central Blood Pressure Measurements and Antihypertensive Therapy: A Consensus Document
Hypertension, July 1, 2007; 50(1): 154 - 160.
[Full Text] [PDF]


Home page
HypertensionHome page
P. Segers, E. R. Rietzschel, M. L. De Buyzere, S. J. Vermeersch, D. De Bacquer, L. M. Van Bortel, G. De Backer, T. C. Gillebert, P. R. Verdonck, and on behalf of the Asklepios investigators
Noninvasive (Input) Impedance, Pulse Wave Velocity, and Wave Reflection in Healthy Middle-Aged Men and Women
Hypertension, June 1, 2007; 49(6): 1248 - 1255.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. H. Vanmolkot, L. M. Van Bortel, and J. N. de Hoon
Altered arterial function in migraine of recent onset
Neurology, May 8, 2007; 68(19): 1563 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al.
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Segers, J. De Backer, D. Devos, S. I. Rabben, T. C. Gillebert, L. M. Van Bortel, J De Sutter, A. De Paepe, and P. R. Verdonck
Aortic reflection coefficients and their association with global indexes of wave reflection in healthy controls and patients with Marfan's syndrome
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2385 - H2392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Flack
Noninvasive Hemodynamic Measurements: An Important Advance in Individualizing Drug Therapies for Hypertensive Patients
Hypertension, April 1, 2006; 47(4): 646 - 647.
[Full Text] [PDF]


Home page
HypertensionHome page
M. F. O'Rourke, A. Adji, S. Hoegler, F. Verbeke, P. Segers, R. Vanholder, P. Verdonck, and L. M. Van Bortel
Calibration of Noninvasively Recorded Upper-Limb Pressure Waves
Hypertension, November 1, 2005; 46(5): e15 - e16.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/1/244    most recent
01.HYP.0000166723.07809.7ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verbeke, F.
Right arrow Articles by Van Bortel, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbeke, F.
Right arrow Articles by Van Bortel, L. M.
Related Collections
Right arrow Hypertension - basic studies
Right arrow Other diagnostic testing